Evidence map›Paper›PMID 35991866›Full record

ArticleFrontiers in pharmacology2022

Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis.

Zhenyu Zhu, Yuxiu Gu, Cuirong Zeng, Man Yang, Hao Yu, Hui Chen, Bikui Zhang, Hualin Cai

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Fruit-Based Diet and Gut Health: A Review.Food science & nutrition · 2025
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Zhenyu ZhuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Yuxiu GuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Cuirong ZengDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Man YangSchool of Pharmacy, Changsha Medical University, Changsha, China.
Hao YuSchool of Pharmacy, Hunan University of Medicine, Changsha, China.
Hui ChenDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Bikui ZhangDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Hualin CaiDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Second Xiangya Hospital of Central South University · CNCentral South University · CNChangsha Medical University · CNHunan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gut microbiomegut microbiota-brain axislipid disturbancesolanzapinevagus nerve

Identifiers

PMID35991866
PMCPMC9388751
OpenAlexW4289890853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.